close
MENU
3 mins to read

Why Fonterra may have dodged China’s ‘commercial casualty’ bullet

Jamie Ball
Fri, 29 Aug 2014

Fonterra [NZX: FCG] needed to find a local partner if it intended to be relevant in the Chinese infant formula market and not end up a "commercial casualty," Lincoln University agribusiness professor Keith Woodford says.

“Fonterra has neither the capital nor expertise in consumer markets to

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Jamie Ball
Fri, 29 Aug 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Why Fonterra may have dodged China’s ‘commercial casualty’ bullet
40891
true